Article ID Journal Published Year Pages File Type
8454775 Lung Cancer 2016 6 Pages PDF
Abstract
Within this single institution retrospective analysis, patients with advanced NSCLC and a KRAS activating mutation exhibited inferior responses to cytotoxic chemotherapy and decreased survival compared to patients with advanced NSCLC and no KRAS mutation.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer
Authors
, , , , , ,